About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSoutheastern U.S.
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
12
As Collaborator
0
Total Enrollment
2,428
By Phase
PHASE3: 10PHASE2: 2
By Status
COMPLETED: 11RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05724446Lead Sponsor
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
PHASE3Recruiting
60 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2025
NCT04246801Lead Sponsor
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
PHASE3Completed
250 participants
Started: Jun 10, 2020 · Completed: May 19, 2021
NCT03686397Lead Sponsor
SVT-15652 Otic Solution for the Treatment of Otomycosis.
PHASE3Completed
194 participants
Started: Jun 9, 2020 · Completed: Oct 19, 2021
NCT04249076Lead Sponsor
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
PHASE3Completed
215 participants
Started: Jun 4, 2020 · Completed: Apr 14, 2021
NCT03686384Lead Sponsor
SVT-15652 Otic Solution for the Treatment of Otomycosis
PHASE3Completed
217 participants
Started: Feb 27, 2020 · Completed: Oct 25, 2021
Locations (1)
Headquarters
Miami, FL, United States
Map
Loading map...